Holen Sie sich die Stockscreener-App
734.47
0.18%
-1.835
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NOC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Northrop Grumman Corp-Aktie (NOC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
12.37%
11,712.00
|
10,423.00 | 10,351.00 | 9,468.00 | 10,686.00 |
| Operating Expenses |
13.72%
10,441.00
|
9,181.00 | 9,157.00 | 8,895.00 | 9,597.00 |
| Benefits Costs and Expenses |
9.58%
9,972.00
|
9,100.00 | 8,924.00 | 8,890.00 | 9,135.00 |
| Costs And Expenses |
9.58%
9,972.00
|
9,100.00 | 8,924.00 | 8,890.00 | 9,135.00 |
| Operating Income/Loss |
2.33%
1,271.00
|
1,242.00 | 1,425.00 | 573.00 | 1,089.00 |
| Interest And Debt Expense |
8.70%
175.00
|
161.00 | 173.00 | 156.00 | 160.00 |
| Income/Loss From Continuing Operations Before Tax |
31.52%
1,740.00
|
1,323.00 | 1,427.00 | 578.00 | 1,551.00 |
| Income Tax Expense/Benefit |
40.36%
313.00
|
223.00 | 253.00 | 97.00 | 287.00 |
| Income/Loss From Continuing Operations After Tax |
29.73%
1,427.00
|
1,100.00 | 1,174.00 | 481.00 | 1,264.00 |
Net Income/Loss
|
29.73%
1,427.00
|
1,100.00 | 1,174.00 | 481.00 | 1,264.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
100.21%
-0.30
|
143.10 | 143.70 | 144.60 | -0.50 |
| Diluted Average Shares |
100.21%
-0.30
|
143.50 | 144.00 | 144.90 | -0.50 |
| Basic Earnings Per Share |
29.78%
9.98
|
7.69 | 8.17 | 3.33 | 8.66 |
| Diluted Earnings Per Share |
29.86%
9.96
|
7.67 | 8.15 | 3.32 | 8.65 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.61%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):